IART — Integra LifeSciences Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Integra LifeSciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	470	513	457	309	274
Net Total Accounts Receivable
Net Total Receivables	233	243	274	259	272
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,237	1,154	1,161	1,058	1,082
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	371	396	460	496	550
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	3,615	3,782	3,890	3,782	4,037
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	401	340	321	307	922
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	2,100	2,098	2,085	2,194	2,492
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,515	1,685	1,804	1,588	1,545
Total Liabilities & Shareholders' Equity	3,615	3,782	3,890	3,782	4,037
Total Common Shares Outstanding